Advanced Therapy Clinical Trials Oversight in the UK
Advanced Therapy Clinical Trials Oversight in the UK MHRA Oversight of Advanced Therapy Clinical Trials in the United Kingdom Advanced Therapy Medicinal Products (ATMPs), including gene therapies, cell therapies, and tissue-engineered products, represent the cutting edge of medical innovation. In the United Kingdom (UK), these products require rigorous oversight due to their complexity, potential long-term…
Read More “Advanced Therapy Clinical Trials Oversight in the UK” »